Segmentation by type distinguishes the material and design architecture of orthopedic burs, each influencing cost structure and adoption rate. Metal burs, typically fabricated from stainless‑steel or titanium, dominate the high‑performance tier, capturing approximately 40 % of the market due to their durability in high‑load joint spaces. Polymer burs, produced from PEEK or UHMWPE, represent the largest share at 45 %, favored for their low friction, biocompatibility, and lower price point, especially in outpatient settings. Composite burs, integrating metal cores with polymer sleeves, hold a niche 10 % share, offering a balance of strength and flexibility for complex procedures. Biologic burs, derived from processed autograft tissue, remain emergent, accounting for the remaining 5 % as regenerative‑medicine protocols gain traction. This type‑based taxonomy clarifies how material selection drives pricing, reimbursement, and ultimately the total addressable market within the Orthopedic Burs sector.